Thursday, Apr 25 2024 | Time 06:34 Hrs(IST)
image
Business EconomyPosted at: Mar 15 2020 8:23PM


Innoplexus Opens Its Ontosight® AI Search Platform to COVID-19 Research

FRANKFURT, Germany, Mar 15, 2020 /PRNewswire/ -- Innoplexus AG has made its proprietary Ontosight® AI search platform available to medical researchers around the globe to help fight the COVID-19 pandemic with immediate effect. The platform is already being used by researchers from Germany, USA, and India.
Innoplexus Logo (PRNewsfoto/Innoplexus AG)
'Flattening the curve' necessitates health organizations to take on early measures focused on containment. Various countries, such as Taiwan, Singapore, and Japan, have already succeeded in the containment of the Coronavirus. The use of Big Data analytics, new technologies, and proactive testing all played a central role in making this possible.
Currently, most countries lack this specific expertise and are spending extensive resources on managing mitigation, to make the virus as inoffensive as possible. The better a country's healthcare system can function, the lower the mortality rate, and the higher the share of the population that can be treated.
Innoplexus' Commitment to Improve Global Health Response Rates
Innoplexus is committed to enable rapid research for the development of tests and treatments for COVID-19. Today the company announced that it will share an open license for general access to its Ontosight® AI Search platform to help researchers learn more about the novel coronavirus. Government science advisers in a dozen countries are asking to make data on the disease more widely available. Innoplexus is thereby answering the call of the US, Australia, Brazil, Canada, Germany, India, Italy, Japan, New Zealand, Singapore, South Korea, and the UK to make publications available to the research community.
In an Innoplexus blog post "Coronavirus: Why governments need a decisive action plan" on their website, they look at global learnings and hope to aid and contribute to COVID-19 research by sharing their platform tools to assist research team's efforts.
"We hope that we can contribute to the scientific community's research efforts of how the disease functions and spreads, to be able to assist in hypothesis generation as a predictive platform for ongoing and future work to develop therapeutics," said Gunjan Bhardwaj, CEO of Innoplexus AG.
"We realize that the work of many other labs and organizations will be needed around the globe to respond to COVID-19 with speed and agility. Innoplexus hopes to add impact to these efforts."
Innoplexus
Innoplexus is a leading global AI-based platform for drug discovery and development with over 250 employees and 100+ patent applications including 12 grants in artificial intelligence, machine learning, and blockchain technologies. Innoplexus' solutions can generate real-time insights from hundreds of terabytes of structured and unstructured private and public data, thereby facilitating continuous, informed decision-making for its customer base at an unprecedented speed. Founded in 2015, Innoplexus AG is headquartered in Eschborn, Germany, with offices in Pune, India, as well as Hoboken, and San Francisco, United States.
(Disclaimer--Features may vary depending on the regions; subject to change without notice.)
Logo - https://mma.prnewswire.com/media/1134125/Innoplexus_Logo.jpg
Contact:
Jakob Semmler
Marketing
Innoplexus AG
Frankfurter Straße 27, 65760 Eschborn, Germany.
Phone: +49 6196 9677 311
Email: [email protected]
www.innoplexus.com
Please log in to get detailed story.
Tags: #Innoplexus Opens Its Ontosight® AI Search Platform to COVID-19 Research
More News

NSE launches derivatives on Nifty Next 50 Index

24 Apr 2024 | 9:16 PM

Mumbai, Apr 24 (UNI) National Stock Exchange of India Ltd (NSE), the world’s largest derivatives exchange for consecutive fifth year in a row in the year 2023 based on contracts traded as published by FIA, launched futures and options contracts on the Nifty Next 50 Index on Wednesday.

see more..

KABIL signs MoU with CSIR-NGRI for geophysical investigations

24 Apr 2024 | 7:47 PM

Bhubaneswar, April 24 (UNI) Khanij Bidesh India Limited (KABIL) has signed a Memorandum of Understanding (MoU) with the Council of Scientific and Industrial Research - National Geophysical Research Institute (CSIR-NGRI) to foster a long-term collaboration in the field of geophysical investigations to bolster its ongoing projects and activities in critical and strategic minerals.

see more..

Dish TV revolutionises entertainment with ‘Dish TV Smart+’ services

24 Apr 2024 | 7:31 PM

Kolkata, Apr 24 (UNI) Dish TV has taken a path-breaking initiative to redefine the entertainment experience in India.

see more..

TRAI recommends sharing of active, passive infra by telecom providers

24 Apr 2024 | 7:03 PM

New Delhi, April 24 (UNI) With a view to improve quality of services and reducing cost, the telecom regulator TRAI on Wednesday recommended sharing of active and passive infrastructure among telecom service providers, a move that would help setting up network quickly across the nation.

see more..

REC to provide loan of Rs 1869 cr to Chenab Valley Power Project in J&K

24 Apr 2024 | 6:38 PM

New Delhi, April 24 (UNI) State-owned non-banking finance company REC Limited has signed an agreement with Chenab Valley Power Project Private Limited (CVPPPL), under which it will provide financial assistance of Rs 1,869.265 crore as a term loan.

see more..
image